CALCIUM POLYCARBOPHIL

CALCIUM POLYCARBOPHIL was reported 2995 times

CALCIUM POLYCARBOPHIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE DRUG THERAPY 26 0.0345
1 CREATININE RENAL CLEARANCE INCREASED 22 0.0294
2 SEDATION COMPLICATION 67 0.0262
3 CREATININE RENAL CLEARANCE DECREASED 68 0.0170
4 ANAL INJURY 2 0.0116
5 ELECTROCARDIOGRAM QT SHORTENED 3 0.0099
6 BETA 2 MICROGLOBULIN INCREASED 2 0.0077
7 RENAL SALT-WASTING SYNDROME 3 0.0077
8 RENAL FUNCTION TEST ABNORMAL 34 0.0073
9 BLOOD CALCIUM DECREASED 69 0.0061
10 BLOOD MAGNESIUM ABNORMAL 3 0.0054
11 EUSTACHIAN TUBE DYSFUNCTION 3 0.0052
12 STOMA COMPLICATION 5 0.0049
13 ANASTOMOTIC ULCER 2 0.0043
14 ORTHOSTATIC HYPOTENSION 70 0.0040
15 STRESS URINARY INCONTINENCE 4 0.0037
16 PERIORBITAL PAIN 3 0.0035
17 MASTOIDITIS 3 0.0031
18 PRODUCT DIFFICULT TO SWALLOW 3 0.0030
19 ECHOCARDIOGRAM ABNORMAL 4 0.0029
20 SEDATION 74 0.0028
21 INFUSION SITE MASS 3 0.0028
22 AORTIC VALVE SCLEROSIS 2 0.0027
23 OPEN WOUND 3 0.0027
24 BARRETT'S OESOPHAGUS 2 0.0025
25 FISTULA DISCHARGE 3 0.0024
26 SLEEP TALKING 4 0.0024
27 ALCOHOL WITHDRAWAL SYNDROME 2 0.0023
28 INFUSION SITE RASH 3 0.0022
29 BIOPSY 2 0.0022
30 PERIODONTAL DISEASE 3 0.0021
31 ANIMAL SCRATCH 2 0.0021
32 RED BLOOD CELL COUNT ABNORMAL 3 0.0020
33 STOMA SITE HAEMORRHAGE 3 0.0019
34 GASTROINTESTINAL STOMA COMPLICATION 3 0.0019
35 OSTEOSCLEROSIS 3 0.0019
36 TINEA PEDIS 3 0.0019
37 CYSTITIS INTERSTITIAL 3 0.0019
38 COGNITIVE DISORDER 87 0.0019
39 COSTOCHONDRITIS 3 0.0018
40 MITRAL VALVE PROLAPSE 3 0.0018
41 LARGE INTESTINAL OBSTRUCTION 4 0.0018
42 BENIGN NEOPLASM 2 0.0018
43 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
44 DEPRESSED LEVEL OF CONSCIOUSNESS 69 0.0017
45 VITAMIN B12 DECREASED 5 0.0017
46 FUNGAL SKIN INFECTION 7 0.0017
47 CAROTID ARTERY STENOSIS 6 0.0017
48 FAECAL INCONTINENCE 8 0.0017
49 AORTIC VALVE REPLACEMENT 2 0.0016
50 HYPERPARATHYROIDISM SECONDARY 4 0.0016
51 ADRENAL DISORDER 3 0.0016
52 BILIARY OBSTRUCTION 2 0.0015
53 LOCALISED OEDEMA 7 0.0015
54 HAEMORRHOIDAL HAEMORRHAGE 7 0.0014
55 JAW FRACTURE 3 0.0014
56 PERIODONTITIS 3 0.0014
57 CORNEAL DISORDER 3 0.0014
58 MIDDLE EAR EFFUSION 3 0.0014
59 HYPOMANIA 5 0.0014
60 SEASONAL ALLERGY 19 0.0013
61 INFECTIOUS MONONUCLEOSIS 3 0.0013
62 ASTIGMATISM 2 0.0013
63 BLADDER DISORDER 13 0.0013
64 PRODUCT SIZE ISSUE 7 0.0013
65 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
66 ROSACEA 6 0.0013
67 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
68 VOLVULUS 3 0.0013
69 PROCTALGIA 8 0.0012
70 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
71 BALANCE DISORDER 105 0.0012
72 CHOLECYSTITIS CHRONIC 8 0.0012
73 BUNDLE BRANCH BLOCK LEFT 5 0.0012
74 INTERVERTEBRAL DISC DISORDER 5 0.0012
75 PHYSICAL DECONDITIONING 3 0.0012
76 ACUTE SINUSITIS 2 0.0012
77 MELANOCYTIC NAEVUS 5 0.0011
78 ALOPECIA AREATA 2 0.0011
79 MOBILITY DECREASED 81 0.0011
80 BLOOD POTASSIUM ABNORMAL 3 0.0011
81 TEMPOROMANDIBULAR JOINT SYNDROME 3 0.0011
82 BLOOD SODIUM INCREASED 3 0.0011
83 HYPOPHOSPHATAEMIA 8 0.0011
84 HIATUS HERNIA 14 0.0011
85 ANAL HAEMORRHAGE 3 0.0011
86 PROCTITIS 3 0.0011
87 PRODUCT PREPARATION ISSUE 7 0.0011
88 SKIN ABRASION 5 0.0011
89 PULSE ABSENT 5 0.0011
90 DUODENAL ULCER HAEMORRHAGE 3 0.0010
91 PARANASAL SINUS HYPERSECRETION 4 0.0010
92 HYPERTONIC BLADDER 3 0.0010
93 VULVOVAGINAL PAIN 5 0.0010
94 DYSPNOEA AT REST 3 0.0010
95 ARTERIAL THROMBOSIS 2 0.0010
96 CHOKING 20 0.0010
97 DECREASED INTEREST 6 0.0010
98 OESOPHAGEAL PAIN 4 0.0010
99 DIABETIC NEUROPATHY 5 0.0010
100 SQUAMOUS CELL CARCINOMA OF SKIN 6 0.0010
101 NOCTURIA 12 0.0010
102 VITAMIN B12 DEFICIENCY 4 0.0010
103 KERATITIS 3 0.0010
104 DERMATITIS ACNEIFORM 6 0.0010
105 CARDIOMEGALY 12 0.0010
106 HAEMORRHOIDS 19 0.0010
107 SPINAL STENOSIS 4 0.0010
108 PRE-EXISTING CONDITION IMPROVED 6 0.0010
109 ATRIAL TACHYCARDIA 2 0.0010
110 CONSTIPATION 207 0.0009
111 LUNG NEOPLASM 4 0.0009
112 SKIN EROSION 3 0.0009
113 VULVOVAGINAL DRYNESS 3 0.0009
114 BRUXISM 5 0.0009
115 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
116 OEDEMA MOUTH 3 0.0009
117 POLYP 6 0.0009
118 DIVERTICULUM INTESTINAL 4 0.0009
119 INFUSION SITE HAEMORRHAGE 3 0.0009
120 LIGAMENT RUPTURE 4 0.0009
121 VULVOVAGINAL DISCOMFORT 4 0.0009
122 WHEELCHAIR USER 4 0.0009
123 PLANTAR FASCIITIS 3 0.0009
124 MALNUTRITION 10 0.0009
125 METASTASES TO SPINE 3 0.0009
126 ANAL INCONTINENCE 8 0.0009
127 IRON DEFICIENCY 4 0.0009
128 VASCULAR DEVICE INFECTION 4 0.0009
129 CARBOHYDRATE ANTIGEN 125 INCREASED 3 0.0009
130 ABDOMINAL HERNIA 4 0.0009
131 CARDIAC VALVE DISEASE 5 0.0009
132 REGURGITATION 3 0.0009
133 CERVICAL VERTEBRAL FRACTURE 3 0.0009
134 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
135 NEPHROGENIC ANAEMIA 4 0.0009
136 DECUBITUS ULCER 7 0.0009
137 UMBILICAL HERNIA 4 0.0009
138 HYPOVOLAEMIA 5 0.0009
139 FLANK PAIN 8 0.0009
140 SPINAL COLUMN STENOSIS 4 0.0008
141 GLOSSITIS 3 0.0008
142 COLITIS MICROSCOPIC 4 0.0008
143 DIVERTICULUM 6 0.0008
144 FIBRIN D DIMER INCREASED 3 0.0008
145 APPENDICECTOMY 3 0.0008
146 HYPOVOLAEMIC SHOCK 4 0.0008
147 LIMB OPERATION 4 0.0008
148 PHARYNGITIS STREPTOCOCCAL 9 0.0008
149 INGUINAL HERNIA 5 0.0008
150 SMALL INTESTINAL OBSTRUCTION 10 0.0008
151 SPRUE-LIKE ENTEROPATHY 4 0.0008
152 HOSPICE CARE 8 0.0008
153 CARDIAC MURMUR 7 0.0008
154 ABDOMINAL TENDERNESS 4 0.0008
155 INFUSION SITE SWELLING 5 0.0008
156 MULTIPLE INJURIES 5 0.0008
157 CATHETER SITE INFECTION 3 0.0008
158 DERMATITIS CONTACT 9 0.0008
159 PATHOLOGICAL FRACTURE 4 0.0008
160 SLEEP APNOEA SYNDROME 15 0.0008
161 CLAVICLE FRACTURE 3 0.0008
162 GINGIVAL DISORDER 3 0.0008
163 HAEMOGLOBIN ABNORMAL 5 0.0008
164 FAECES HARD 3 0.0008
165 MUSCLE RUPTURE 3 0.0008
166 EXOSTOSIS 7 0.0008
167 MULTIPLE ALLERGIES 6 0.0008
168 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
169 PROSTATOMEGALY 3 0.0008
170 APPETITE DISORDER 5 0.0008
171 CEREBRAL ATROPHY 3 0.0008
172 FOREIGN BODY 3 0.0007
173 BODY HEIGHT DECREASED 8 0.0007
174 FOOD POISONING 4 0.0007
175 COMPRESSION FRACTURE 4 0.0007
176 DEMYELINATION 3 0.0007
177 HYPERKERATOSIS 4 0.0007
178 GASTRIC ULCER HAEMORRHAGE 4 0.0007
179 GASTROINTESTINAL PERFORATION 3 0.0007
180 ANGIOPATHY 4 0.0007
181 COELIAC DISEASE 7 0.0007
182 INFUSION SITE ERYTHEMA 6 0.0007
183 AORTIC VALVE INCOMPETENCE 3 0.0007
184 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
185 POOR PERIPHERAL CIRCULATION 3 0.0007
186 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
187 ROTATOR CUFF SYNDROME 9 0.0007
188 MICTURITION URGENCY 8 0.0007
189 SALIVARY HYPERSECRETION 7 0.0007
190 IRRITABLE BOWEL SYNDROME 15 0.0007
191 RALES 4 0.0007
192 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
193 SPINAL OSTEOARTHRITIS 6 0.0007
194 GINGIVAL SWELLING 3 0.0007
195 BLOOD POTASSIUM INCREASED 11 0.0007
196 ARTHROPOD BITE 5 0.0007
197 RHINITIS ALLERGIC 3 0.0007
198 SINUS HEADACHE 4 0.0007
199 ATYPICAL PNEUMONIA 2 0.0007
200 SCRATCH 7 0.0007
201 INCONTINENCE 7 0.0007
202 RENAL PAIN 7 0.0007
203 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
204 BONE DISORDER 12 0.0007
205 BRAIN NEOPLASM 6 0.0007
206 MENISCUS INJURY 4 0.0006
207 HYPERCALCAEMIA 8 0.0006
208 FOOD ALLERGY 5 0.0006
209 ANKLE FRACTURE 10 0.0006
210 CONCUSSION 5 0.0006
211 SCOLIOSIS 4 0.0006
212 HYPOALBUMINAEMIA 5 0.0006
213 PERFORMANCE STATUS DECREASED 3 0.0006
214 INFUSION SITE EXTRAVASATION 4 0.0006
215 BASAL CELL CARCINOMA 10 0.0006
216 BLOOD BLISTER 2 0.0006
217 ASPIRATION 7 0.0006
218 CELLULITIS 32 0.0006
219 ABDOMINAL ADHESIONS 2 0.0006
220 BLOOD URINE PRESENT 12 0.0006
221 THERAPEUTIC RESPONSE CHANGED 4 0.0006
222 RENAL CYST 5 0.0006
223 NERVE INJURY 7 0.0006
224 GINGIVAL PAIN 5 0.0006
225 OCULAR DISCOMFORT 7 0.0006
226 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
227 ATELECTASIS 6 0.0006
228 MYASTHENIA GRAVIS 5 0.0006
229 DIZZINESS POSTURAL 6 0.0006
230 MITRAL VALVE INCOMPETENCE 7 0.0006
231 INCOHERENT 4 0.0006
232 GALLBLADDER DISORDER 11 0.0006
233 SHOCK HAEMORRHAGIC 5 0.0006
234 FALL 204 0.0006
235 CHOLECYSTECTOMY 7 0.0006
236 VITREOUS FLOATERS 6 0.0006
237 SOMNAMBULISM 4 0.0006
238 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
239 RECTAL HAEMORRHAGE 26 0.0006
240 SPINAL COMPRESSION FRACTURE 5 0.0006
241 POLLAKIURIA 25 0.0006
242 ANXIETY DISORDER 2 0.0006
243 FULL BLOOD COUNT DECREASED 12 0.0006
244 ABNORMAL LOSS OF WEIGHT 4 0.0006
245 HYPERLIPIDAEMIA 7 0.0006
246 INITIAL INSOMNIA 6 0.0006
247 INCREASED UPPER AIRWAY SECRETION 3 0.0006
248 PERIPHERAL VASCULAR DISORDER 3 0.0006
249 TEMPERATURE INTOLERANCE 6 0.0006
250 VARICOSE VEIN 3 0.0006
251 ORAL PAIN 13 0.0006
252 FOOT FRACTURE 11 0.0006
253 BLOOD MAGNESIUM DECREASED 5 0.0006
254 FAILURE TO THRIVE 3 0.0006
255 LARGE INTESTINE POLYP 4 0.0006
256 HYSTERECTOMY 5 0.0006
257 SINUSITIS 59 0.0006
258 AORTIC STENOSIS 2 0.0006
259 DEMENTIA 16 0.0006
260 ACUTE RESPIRATORY FAILURE 11 0.0006
261 CARPAL TUNNEL SYNDROME 8 0.0006
262 DEFAECATION URGENCY 4 0.0006
263 FOOD CRAVING 3 0.0006
264 GASTRITIS 15 0.0006
265 NEPHROLITHIASIS 26 0.0006
266 IMMUNOSUPPRESSION 5 0.0006
267 LUNG INFILTRATION 5 0.0006
268 SCIATICA 9 0.0006
269 ANORECTAL DISCOMFORT 3 0.0006
270 JOINT INJURY 12 0.0006
271 GOUT 10 0.0006
272 STRESS FRACTURE 3 0.0006
273 GASTROENTERITIS VIRAL 10 0.0006
274 BACK DISORDER 9 0.0006
275 HYPOTENSION 111 0.0006
276 OSTEOMYELITIS 10 0.0006
277 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 3 0.0006
278 PULMONARY THROMBOSIS 6 0.0005
279 FAECES SOFT 4 0.0005
280 OESOPHAGITIS 6 0.0005
281 FAECALOMA 3 0.0005
282 ASTHENOPIA 3 0.0005
283 MOUTH HAEMORRHAGE 4 0.0005
284 URINARY TRACT INFECTION 93 0.0005
285 PROSTATIC DISORDER 3 0.0005
286 DENTAL CARIES 6 0.0005
287 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
288 FEELING DRUNK 4 0.0005
289 COLON CANCER 8 0.0005
290 INTESTINAL PERFORATION 6 0.0005
291 HYDRONEPHROSIS 4 0.0005
292 HEPATIC CIRRHOSIS 10 0.0005
293 BREAST TENDERNESS 4 0.0005
294 ECONOMIC PROBLEM 8 0.0005
295 TROPONIN INCREASED 4 0.0005
296 BOWEL MOVEMENT IRREGULARITY 4 0.0005
297 SKIN ATROPHY 3 0.0005
298 MOUTH SWELLING 3 0.0005
299 ATRIOVENTRICULAR BLOCK 4 0.0005
300 BLOOD PRESSURE SYSTOLIC INCREASED 10 0.0005
301 VIRAL INFECTION 17 0.0005
302 BRAIN FOG 8 0.0005
303 AFFECTIVE DISORDER 4 0.0005
304 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
305 TRICUSPID VALVE INCOMPETENCE 4 0.0005
306 CARDIAC PACEMAKER INSERTION 3 0.0005
307 PROTHROMBIN TIME PROLONGED 3 0.0005
308 AZOTAEMIA 2 0.0005
309 RHINITIS 4 0.0005
310 EMPHYSEMA 5 0.0005
311 SINUS TACHYCARDIA 7 0.0005
312 POST PROCEDURAL INFECTION 4 0.0005
313 VULVOVAGINAL BURNING SENSATION 3 0.0005
314 EAR INFECTION 13 0.0005
315 MUSCLE SPASTICITY 6 0.0005
316 RIB FRACTURE 10 0.0005
317 LIMB DISCOMFORT 15 0.0005
318 CHOLANGITIS 3 0.0005
319 CYST 6 0.0005
320 PNEUMONIA ASPIRATION 12 0.0005
321 TENDERNESS 5 0.0005
322 BLOOD SODIUM DECREASED 9 0.0005
323 BRONCHITIS 35 0.0005
324 FULL BLOOD COUNT ABNORMAL 5 0.0005
325 URINARY INCONTINENCE 14 0.0005
326 CLOSTRIDIUM DIFFICILE COLITIS 5 0.0005
327 EATING DISORDER 10 0.0005
328 POST PROCEDURAL COMPLICATION 9 0.0005
329 HOT FLUSH 35 0.0005
330 POOR QUALITY DRUG ADMINISTERED 3 0.0005
331 ATRIAL FIBRILLATION 45 0.0005
332 DYSURIA 17 0.0005
333 OSTEOPENIA 7 0.0005
334 FAECES DISCOLOURED 10 0.0005
335 ABDOMINAL DISTENSION 48 0.0005
336 SKIN LACERATION 5 0.0005
337 OEDEMA PERIPHERAL 56 0.0005
338 REFUSAL OF TREATMENT BY PATIENT 3 0.0005
339 PAIN IN JAW 13 0.0005
340 INSURANCE ISSUE 7 0.0005
341 CHOLELITHIASIS 15 0.0005
342 HYPOKALAEMIA 21 0.0005
343 COLD SWEAT 8 0.0005
344 ABDOMINAL ABSCESS 2 0.0005
345 BLOOD CREATINE INCREASED 2 0.0005
346 FOOT DEFORMITY 5 0.0005
347 RESPIRATORY RATE INCREASED 4 0.0005
348 URINARY RETENTION 15 0.0004
349 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
350 OSTEOARTHRITIS 19 0.0004
351 NECK PAIN 25 0.0004
352 GASTROOESOPHAGEAL REFLUX DISEASE 36 0.0004
353 BREAST MASS 3 0.0004
354 DYSSTASIA 13 0.0004
355 ULCER HAEMORRHAGE 3 0.0004
356 EYE INFECTION 5 0.0004
357 LEUKOCYTOSIS 8 0.0004
358 ABSCESS 7 0.0004
359 CORONARY ARTERY OCCLUSION 6 0.0004
360 LETHARGY 25 0.0004
361 UROSEPSIS 4 0.0004
362 NERVE COMPRESSION 4 0.0004
363 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
364 TOXICITY TO VARIOUS AGENTS 73 0.0004
365 BLOOD POTASSIUM DECREASED 13 0.0004
366 PULMONARY HYPERTENSION 9 0.0004
367 HYPOMAGNESAEMIA 6 0.0004
368 SPLENOMEGALY 5 0.0004
369 UNRESPONSIVE TO STIMULI 11 0.0004
370 EYE PAIN 24 0.0004
371 HAND FRACTURE 3 0.0004
372 MUSCULOSKELETAL DISORDER 8 0.0004
373 COAGULOPATHY 7 0.0004
374 MUSCULOSKELETAL PAIN 22 0.0004
375 CHOLECYSTITIS 5 0.0004
376 MACULAR DEGENERATION 5 0.0004
377 SUPRAVENTRICULAR TACHYCARDIA 4 0.0004
378 PARAESTHESIA ORAL 6 0.0004
379 BURSITIS 5 0.0004
380 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
381 PERITONEAL DIALYSIS COMPLICATION 3 0.0004
382 PLEURAL EFFUSION 25 0.0004
383 UTERINE LEIOMYOMA 3 0.0004
384 NEUROPATHY PERIPHERAL 39 0.0004
385 ORAL DISORDER 3 0.0004
386 INFLAMMATORY BOWEL DISEASE 4 0.0004
387 GLOMERULAR FILTRATION RATE DECREASED 5 0.0004
388 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
389 BODY TEMPERATURE DECREASED 4 0.0004
390 PARANOIA 7 0.0004
391 FLATULENCE 23 0.0004
392 TOOTH DISORDER 9 0.0004
393 ILEUS 5 0.0004
394 TOOTH EXTRACTION 5 0.0004
395 SPINAL FRACTURE 8 0.0004
396 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
397 WEIGHT DECREASED 111 0.0004
398 DIVERTICULITIS 11 0.0004
399 LYMPHOCYTE COUNT DECREASED 7 0.0004
400 IMPAIRED HEALING 13 0.0004
401 BLOOD COUNT ABNORMAL 6 0.0004
402 COLITIS 15 0.0004
403 HEAD DISCOMFORT 7 0.0004
404 TOOTH ABSCESS 4 0.0004
405 ACIDOSIS 3 0.0004
406 THIRST 7 0.0004
407 BLOOD PRESSURE DECREASED 26 0.0004
408 MUSCLE TWITCHING 9 0.0004
409 RENAL FAILURE CHRONIC 3 0.0004
410 PERICARDIAL EFFUSION 9 0.0004
411 EMOTIONAL DISORDER 12 0.0004
412 LYMPHOMA 6 0.0004
413 INFUSION SITE PAIN 5 0.0004
414 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
415 INJECTION SITE INDURATION 5 0.0004
416 DIPLOPIA 10 0.0004
417 RESTLESS LEGS SYNDROME 7 0.0004
418 APLASTIC ANAEMIA 2 0.0004
419 WEIGHT FLUCTUATION 4 0.0004
420 TRANSFUSION 4 0.0004
421 CHRONIC KIDNEY DISEASE 29 0.0004
422 JOINT STIFFNESS 10 0.0004
423 HAEMATURIA 13 0.0004
424 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
425 FURUNCLE 3 0.0004
426 RENAL FAILURE ACUTE 16 0.0004
427 CYSTITIS 12 0.0004
428 ATRIAL FLUTTER 3 0.0004
429 MIDDLE INSOMNIA 7 0.0004
430 ANAL FISTULA 2 0.0004
431 MALIGNANT MELANOMA 5 0.0004
432 ANAL FISSURE 2 0.0004
433 JOINT RANGE OF MOTION DECREASED 5 0.0004
434 PHOTOPHOBIA 7 0.0004
435 LOCALISED INFECTION 9 0.0004
436 RHINORRHOEA 24 0.0004
437 SINUS CONGESTION 5 0.0004
438 POLYURIA 3 0.0004
439 ABNORMAL FAECES 3 0.0004
440 DYSPEPSIA 36 0.0004
441 DRUG INTERACTION 58 0.0004
442 METASTASES TO BONE 6 0.0004
443 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 19 0.0004
444 EPISTAXIS 27 0.0004
445 PROCEDURAL PAIN 10 0.0004
446 MENTAL STATUS CHANGES 10 0.0004
447 FUNGAL INFECTION 12 0.0004
448 ORAL DISCOMFORT 5 0.0004
449 BLOOD UREA INCREASED 6 0.0004
450 SKIN FISSURES 7 0.0004
451 COLITIS ULCERATIVE 16 0.0004
452 MASS 5 0.0004
453 SLEEP DISORDER 25 0.0004
454 HEMIPARESIS 6 0.0004
455 SINUS DISORDER 7 0.0004
456 DIARRHOEA 228 0.0004
457 FACIAL PARALYSIS 3 0.0004
458 UPPER LIMB FRACTURE 7 0.0004
459 SCAB 4 0.0004
460 ERECTILE DYSFUNCTION 9 0.0004
461 DRUG ABUSE 29 0.0003
462 HAEMATOMA 9 0.0003
463 MUSCLE STRAIN 3 0.0003
464 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
465 HYPOKINESIA 5 0.0003
466 DEAFNESS 9 0.0003
467 GRIP STRENGTH DECREASED 3 0.0003
468 ILLNESS 35 0.0003
469 COVID-19 PNEUMONIA 4 0.0003
470 BLOOD IRON DECREASED 4 0.0003
471 ATAXIA 4 0.0003
472 FACIAL PAIN 3 0.0003
473 PULMONARY MASS 5 0.0003
474 ASTHENIA 126 0.0003
475 GASTROINTESTINAL INFECTION 3 0.0003
476 HAEMORRHAGE INTRACRANIAL 5 0.0003
477 OEDEMA 18 0.0003
478 DEHYDRATION 44 0.0003
479 PANIC ATTACK 12 0.0003
480 END STAGE RENAL DISEASE 6 0.0003
481 RETCHING 7 0.0003
482 NO THERAPEUTIC RESPONSE 4 0.0003
483 RESPIRATORY DISTRESS 9 0.0003
484 INCREASED TENDENCY TO BRUISE 3 0.0003
485 TRANSIENT ISCHAEMIC ATTACK 11 0.0003
486 MUSCULAR WEAKNESS 37 0.0003
487 ANAEMIA 62 0.0003
488 PHARYNGEAL OEDEMA 5 0.0003
489 COVID-19 57 0.0003
490 DEVICE RELATED INFECTION 5 0.0003
491 SPINAL OPERATION 4 0.0003
492 THYROID DISORDER 5 0.0003
493 PRODUCT DISTRIBUTION ISSUE 3 0.0003
494 NASAL CONGESTION 19 0.0003
495 GENERALISED OEDEMA 4 0.0003
496 DYSGEUSIA 24 0.0003
497 ABDOMINAL PAIN 75 0.0003
498 CONTUSION 31 0.0003
499 ERYTHEMA MULTIFORME 3 0.0003
500 BLOOD CREATININE INCREASED 21 0.0003
501 DEFORMITY 3 0.0003
502 PAIN 197 0.0003
503 GASTRIC DISORDER 11 0.0003
504 OXYGEN SATURATION DECREASED 18 0.0003
505 MEMORY IMPAIRMENT 44 0.0003
506 LACERATION 3 0.0003
507 SQUAMOUS CELL CARCINOMA 3 0.0003
508 DECREASED APPETITE 74 0.0003
509 INTESTINAL OBSTRUCTION 12 0.0003
510 NIGHTMARE 11 0.0003
511 HYPOCALCAEMIA 6 0.0003
512 SPINAL DISORDER 3 0.0003
513 OSTEOPOROSIS 13 0.0003
514 HEAD INJURY 10 0.0003
515 INTERNATIONAL NORMALISED RATIO INCREASED 9 0.0003
516 PNEUMOTHORAX 5 0.0003
517 RASH MACULAR 11 0.0003
518 INCREASED APPETITE 6 0.0003
519 HYPERSOMNIA 9 0.0003
520 STOMATITIS 19 0.0003
521 HERPES ZOSTER 18 0.0003
522 WEIGHT INCREASED 70 0.0003
523 DEPRESSION 71 0.0003
524 THROAT IRRITATION 14 0.0003
525 GASTROINTESTINAL HAEMORRHAGE 26 0.0003
526 HIP FRACTURE 10 0.0003
527 HYPERCHOLESTEROLAEMIA 3 0.0003
528 SINUS BRADYCARDIA 3 0.0003
529 HERNIA 6 0.0003
530 ERUCTATION 6 0.0003
531 PARKINSONISM 3 0.0003
532 DYSPHAGIA 29 0.0003
533 THERAPY CHANGE 3 0.0003
534 KNEE OPERATION 3 0.0003
535 ANHEDONIA 8 0.0003
536 ORAL CANDIDIASIS 4 0.0003
537 IMMUNE SYSTEM DISORDER 4 0.0003
538 TOOTH INFECTION 4 0.0003
539 GAIT DISTURBANCE 58 0.0003
540 DISORIENTATION 12 0.0003
541 CHEST PAIN 56 0.0003
542 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
543 BLOOD PRESSURE ABNORMAL 6 0.0003
544 DIABETES MELLITUS 23 0.0003
545 FEELING ABNORMAL 72 0.0003
546 BLOOD CHOLESTEROL INCREASED 14 0.0003
547 OVARIAN CYST 3 0.0003
548 PNEUMONIA 97 0.0003
549 FATIGUE 233 0.0003
550 PERITONITIS BACTERIAL 3 0.0003
551 CORONARY ARTERY DISEASE 9 0.0003
552 INFECTION 43 0.0003
553 CANDIDA INFECTION 5 0.0003
554 TASTE DISORDER 6 0.0003
555 PRODUCT TASTE ABNORMAL 4 0.0003
556 EYELID PTOSIS 3 0.0003
557 DYSPNOEA 167 0.0003
558 FLUID RETENTION 15 0.0003
559 BLOOD PRESSURE INCREASED 45 0.0003
560 DISEASE RECURRENCE 14 0.0003
561 IMPAIRED GASTRIC EMPTYING 4 0.0003
562 NEUTROPHIL COUNT INCREASED 3 0.0003
563 DEEP VEIN THROMBOSIS 19 0.0003
564 EAR DISCOMFORT 3 0.0003
565 HALLUCINATION 22 0.0003
566 BLOOD PRESSURE FLUCTUATION 7 0.0003
567 VISION BLURRED 40 0.0003
568 CENTRAL NERVOUS SYSTEM LESION 4 0.0003
569 PROSTATIC SPECIFIC ANTIGEN INCREASED 4 0.0003
570 PALPITATIONS 34 0.0003
571 HAEMATOCHEZIA 16 0.0003
572 MUSCLE SPASMS 53 0.0003
573 EYE DISCHARGE 3 0.0003
574 MYALGIA 49 0.0003
575 HYPERTENSION 61 0.0003
576 NEURALGIA 7 0.0003
577 ARTHROPATHY 16 0.0003
578 ROAD TRAFFIC ACCIDENT 12 0.0003
579 LOCAL SWELLING 5 0.0003
580 THROMBOSIS 23 0.0003
581 FLUSHING 29 0.0003
582 HEART RATE DECREASED 10 0.0003
583 METASTASES TO LIVER 5 0.0003
584 BACK PAIN 66 0.0003
585 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
586 DRUG ERUPTION 5 0.0003
587 DIALYSIS 4 0.0003
588 UPPER RESPIRATORY TRACT INFECTION 13 0.0003
589 BREAST PAIN 3 0.0003
590 MOVEMENT DISORDER 9 0.0003
591 PARALYSIS 4 0.0003
592 POOR QUALITY SLEEP 6 0.0003
593 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
594 ABDOMINAL PAIN UPPER 57 0.0003
595 TOOTHACHE 5 0.0003
596 HYPOAESTHESIA 41 0.0003
597 HYPOPHAGIA 7 0.0003
598 DIZZINESS 135 0.0003
599 INSOMNIA 72 0.0003
600 CONJUNCTIVITIS 5 0.0003
601 RENAL INJURY 8 0.0003
602 GAIT INABILITY 9 0.0003
603 IMMUNODEFICIENCY 4 0.0003
604 GLOSSODYNIA 6 0.0003
605 HAEMORRHAGE 28 0.0003
606 COUGH 75 0.0003
607 SWELLING 25 0.0003
608 BLISTER 15 0.0003
609 CHROMATURIA 6 0.0003
610 HEART RATE IRREGULAR 6 0.0003
611 DYSPNOEA EXERTIONAL 10 0.0003
612 APHASIA 8 0.0003
613 LACRIMATION INCREASED 8 0.0003
614 FRACTURE 5 0.0003
615 RENAL FAILURE 35 0.0003
616 INTENTIONAL PRODUCT USE ISSUE 23 0.0003
617 CARDIAC FAILURE CONGESTIVE 21 0.0003
618 GASTRIC HAEMORRHAGE 3 0.0003
619 PULMONARY FIBROSIS 5 0.0003
620 DRUG PRESCRIBING ERROR 5 0.0003
621 METASTASES TO LUNG 3 0.0003
622 DELIRIUM 9 0.0003
623 FREQUENT BOWEL MOVEMENTS 7 0.0003
624 PAIN IN EXTREMITY 76 0.0003
625 LUNG INFECTION 4 0.0003
626 APNOEA 2 0.0003
627 GASTROINTESTINAL DISORDER 23 0.0003
628 BURNING SENSATION 18 0.0003
629 ACUTE MYELOID LEUKAEMIA 4 0.0003
630 PLASMA CELL MYELOMA 10 0.0003
631 HYPOACUSIS 11 0.0003
632 LYMPHADENOPATHY 9 0.0003
633 PARAESTHESIA 40 0.0003
634 PRODUCT USE COMPLAINT 4 0.0003
635 HAEMOGLOBIN DECREASED 26 0.0003
636 CATARACT 15 0.0003
637 ULCER 4 0.0003
638 PRODUCTIVE COUGH 12 0.0003
639 OBESITY 4 0.0003
640 HYPOTHYROIDISM 8 0.0003
641 WRIST FRACTURE 3 0.0003
642 PRODUCT USE IN UNAPPROVED INDICATION 62 0.0002
643 ANXIETY 71 0.0002
644 INCORRECT DRUG ADMINISTRATION DURATION 7 0.0002
645 HEADACHE 156 0.0002
646 NERVOUSNESS 13 0.0002
647 HYPONATRAEMIA 14 0.0002
648 NIGHT SWEATS 8 0.0002
649 INTENTIONAL SELF-INJURY 5 0.0002
650 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
651 HYPERGLYCAEMIA 9 0.0002
652 MUSCLE TIGHTNESS 4 0.0002
653 SCHIZOPHRENIA 3 0.0002
654 PULMONARY OEDEMA 11 0.0002
655 INTENTIONAL DOSE OMISSION 7 0.0002
656 RED BLOOD CELL COUNT DECREASED 7 0.0002
657 ENCEPHALOPATHY 6 0.0002
658 ANGINA PECTORIS 7 0.0002
659 NASOPHARYNGITIS 45 0.0002
660 SOMNOLENCE 49 0.0002
661 EYE DISORDER 8 0.0002
662 EYE IRRITATION 14 0.0002
663 OSTEONECROSIS OF JAW 6 0.0002
664 HEART RATE INCREASED 24 0.0002
665 DISTURBANCE IN ATTENTION 13 0.0002
666 RASH PRURITIC 13 0.0002
667 TINNITUS 11 0.0002
668 DYSPHONIA 14 0.0002
669 INTENTIONAL DRUG MISUSE 5 0.0002
670 NAUSEA 189 0.0002
671 WITHDRAWAL SYNDROME 10 0.0002
672 TYPE 2 DIABETES MELLITUS 8 0.0002
673 MOUTH ULCERATION 5 0.0002
674 HALLUCINATION, VISUAL 5 0.0002
675 CONFUSIONAL STATE 38 0.0002
676 CHEST DISCOMFORT 24 0.0002
677 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
678 ANURIA 2 0.0002
679 SKIN CANCER 5 0.0002
680 SKIN ULCER 6 0.0002
681 OCULAR HYPERAEMIA 11 0.0002
682 PYREXIA 80 0.0002
683 INCORRECT PRODUCT ADMINISTRATION DURATION 5 0.0002
684 WHITE BLOOD CELL COUNT DECREASED 25 0.0002
685 CARDIAC ARREST 19 0.0002
686 PLATELET COUNT INCREASED 3 0.0002
687 MULTIPLE SCLEROSIS 11 0.0002
688 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
689 ARTHRITIS 18 0.0002
690 HYPERKALAEMIA 8 0.0002
691 HOSPITALISATION 35 0.0002
692 PULMONARY CONGESTION 3 0.0002
693 OROPHARYNGEAL PAIN 21 0.0002
694 RENAL IMPAIRMENT 19 0.0002
695 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 16 0.0002
696 RASH MACULO-PAPULAR 5 0.0002
697 NERVOUS SYSTEM DISORDER 7 0.0002
698 RASH PAPULAR 5 0.0002
699 FEAR 6 0.0002
700 UVEITIS 3 0.0002
701 NEUTROPHIL COUNT DECREASED 9 0.0002
702 MIGRAINE 21 0.0002
703 ACCIDENTAL OVERDOSE 8 0.0002
704 PRURITUS 84 0.0002
705 ABNORMAL DREAMS 6 0.0002
706 TREMOR 36 0.0002
707 PLATELET COUNT DECREASED 23 0.0002
708 HUNGER 3 0.0002
709 HEPATIC STEATOSIS 4 0.0002
710 WOUND 6 0.0002
711 THERAPY CESSATION 11 0.0002
712 PERIPHERAL SWELLING 33 0.0002
713 APPENDICITIS 2 0.0002
714 ALOPECIA 42 0.0002
715 VERTIGO 13 0.0002
716 STAPHYLOCOCCAL INFECTION 7 0.0002
717 LYMPHOPENIA 3 0.0002
718 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
719 VISUAL ACUITY REDUCED 7 0.0002
720 GASTRIC ULCER 4 0.0002
721 SPEECH DISORDER 11 0.0002
722 FEELING JITTERY 4 0.0002
723 ARTHRALGIA 87 0.0002
724 ABDOMINAL DISCOMFORT 35 0.0002
725 LOWER LIMB FRACTURE 4 0.0002
726 MYELODYSPLASTIC SYNDROME 3 0.0002
727 ANOSMIA 3 0.0002
728 MENTAL DISORDER 9 0.0002
729 PRESCRIBED OVERDOSE 4 0.0002
730 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
731 MENTAL IMPAIRMENT 5 0.0002
732 FLUID OVERLOAD 3 0.0002
733 FIBROMYALGIA 5 0.0002
734 GASTROENTERITIS 3 0.0002
735 UNDERDOSE 15 0.0002
736 MUSCULOSKELETAL STIFFNESS 18 0.0002
737 AUTOIMMUNE DISORDER 2 0.0002
738 BONE PAIN 12 0.0002
739 KIDNEY INFECTION 4 0.0002
740 INJECTION SITE URTICARIA 5 0.0002
741 ASTHMA 23 0.0002
742 LABORATORY TEST ABNORMAL 6 0.0002
743 CARDIOMYOPATHY 3 0.0002
744 ACUTE KIDNEY INJURY 31 0.0002
745 SKIN HAEMORRHAGE 3 0.0002
746 DISABILITY 4 0.0002
747 HAEMATOCRIT DECREASED 4 0.0002
748 SKIN EXFOLIATION 17 0.0002
749 CEREBROVASCULAR ACCIDENT 34 0.0002
750 THERAPEUTIC RESPONSE UNEXPECTED 9 0.0002
751 AGEUSIA 5 0.0002
752 AMNESIA 13 0.0002
753 INJURY 14 0.0002
754 HYPOXIA 7 0.0002
755 UNEVALUABLE EVENT 15 0.0002
756 ABDOMINAL PAIN LOWER 5 0.0002
757 SEPSIS 22 0.0002
758 CARDIOVASCULAR DISORDER 5 0.0002
759 INJECTION SITE RASH 6 0.0002
760 HEPATITIS 5 0.0002
761 PRODUCT PREPARATION ERROR 4 0.0002
762 LUNG NEOPLASM MALIGNANT 8 0.0002
763 HYPERHIDROSIS 25 0.0002
764 ANAPHYLACTIC SHOCK 5 0.0002
765 MUSCULOSKELETAL CHEST PAIN 3 0.0002
766 TENDONITIS 3 0.0002
767 FEMUR FRACTURE 6 0.0002
768 PERITONITIS 4 0.0002
769 EXPOSURE VIA SKIN CONTACT 5 0.0002
770 RESPIRATORY FAILURE 14 0.0002
771 ECZEMA 10 0.0002
772 PRODUCT SUBSTITUTION ISSUE 11 0.0002
773 DERMATITIS 4 0.0002
774 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
775 VOMITING 89 0.0002
776 RESPIRATORY TRACT CONGESTION 3 0.0002
777 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 34 0.0002
778 RASH ERYTHEMATOUS 9 0.0002
779 SURGERY 11 0.0002
780 BLOOD GLUCOSE DECREASED 9 0.0002
781 IMPAIRED WORK ABILITY 4 0.0002
782 DRUG INTOLERANCE 18 0.0002
783 LIVER FUNCTION TEST INCREASED 4 0.0002
784 DYSARTHRIA 7 0.0002
785 RASH 81 0.0002
786 WHEEZING 11 0.0002
787 PRURITUS GENERALISED 4 0.0002
788 DRY MOUTH 15 0.0002
789 CONDITION AGGRAVATED 56 0.0002
790 LIMB INJURY 5 0.0002
791 SEPTIC SHOCK 8 0.0002
792 PRODUCT DOSE OMISSION ISSUE 54 0.0002
793 MOOD ALTERED 5 0.0002
794 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
795 MANIA 3 0.0002
796 DRUG DOSE OMISSION 30 0.0002
797 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
798 DRUG LEVEL INCREASED 3 0.0002
799 EXPIRED PRODUCT ADMINISTERED 6 0.0002
800 LIVER DISORDER 8 0.0002
801 SKIN DISORDER 6 0.0002
802 FEELING COLD 5 0.0002
803 LOSS OF CONSCIOUSNESS 23 0.0002
804 FEELING HOT 11 0.0002
805 HAEMOPTYSIS 5 0.0002
806 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
807 SNEEZING 4 0.0002
808 MALAISE 78 0.0002
809 DISEASE PROGRESSION 21 0.0002
810 METRORRHAGIA 3 0.0002
811 RENAL DISORDER 8 0.0002
812 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 4 0.0002
813 OVERDOSE 37 0.0002
814 DEVICE USE ISSUE 3 0.0002
815 PANCREATITIS 9 0.0002
816 PRODUCT USE ISSUE 32 0.0002
817 SYNCOPE 17 0.0002
818 THROMBOCYTOPENIA 19 0.0002
819 ACUTE MYOCARDIAL INFARCTION 5 0.0002
820 PSYCHOTIC DISORDER 5 0.0002
821 NEUTROPENIA 23 0.0002
822 TACHYCARDIA 15 0.0002
823 BACTERAEMIA 2 0.0002
824 CEREBRAL HAEMORRHAGE 6 0.0002
825 URTICARIA 28 0.0002
826 JOINT SWELLING 20 0.0002
827 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
828 CRYING 6 0.0002
829 ADRENAL INSUFFICIENCY 2 0.0002
830 PRESYNCOPE 4 0.0002
831 RESTLESSNESS 6 0.0002
832 CEREBRAL INFARCTION 4 0.0002
833 INJECTION SITE BRUISING 13 0.0002
834 INJECTION SITE HAEMORRHAGE 13 0.0002
835 INJECTION SITE MASS 6 0.0002
836 OFF LABEL USE 142 0.0002
837 ABASIA 4 0.0002
838 VISUAL IMPAIRMENT 20 0.0002
839 EYE SWELLING 6 0.0002
840 PANCYTOPENIA 9 0.0002
841 THINKING ABNORMAL 3 0.0002
842 BACTERIAL INFECTION 3 0.0002
843 CARDIAC DISORDER 15 0.0002
844 DRY EYE 8 0.0002
845 SWOLLEN TONGUE 5 0.0002
846 RHEUMATOID ARTHRITIS 18 0.0002
847 PULMONARY EMBOLISM 15 0.0002
848 HAEMATEMESIS 4 0.0002
849 CONVULSION 9 0.0002
850 ADVERSE DRUG REACTION 14 0.0002
851 SEIZURE 18 0.0002
852 GLAUCOMA 3 0.0002
853 INFLAMMATION 8 0.0002
854 EAR PAIN 3 0.0002
855 PHARMACEUTICAL PRODUCT COMPLAINT 4 0.0002
856 ORAL HERPES 3 0.0002
857 RESPIRATORY TRACT INFECTION 4 0.0002
858 INFLUENZA 17 0.0002
859 BEDRIDDEN 2 0.0002
860 DEPRESSED MOOD 8 0.0002
861 HYPERSENSITIVITY 28 0.0002
862 BRADYCARDIA 8 0.0002
863 FEBRILE NEUTROPENIA 10 0.0002
864 ASPARTATE AMINOTRANSFERASE INCREASED 8 0.0002
865 PRESCRIBED UNDERDOSE 3 0.0002
866 NEOPLASM MALIGNANT 10 0.0001
867 INJECTION SITE PRURITUS 10 0.0001
868 EYE PRURITUS 5 0.0001
869 INTENTIONAL PRODUCT MISUSE 13 0.0001
870 BLINDNESS 6 0.0001
871 BODY TEMPERATURE INCREASED 3 0.0001
872 PALLOR 4 0.0001
873 TREATMENT NONCOMPLIANCE 8 0.0001
874 SKIN LESION 4 0.0001
875 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 8 0.0001
876 APPLICATION SITE RASH 2 0.0001
877 INTERSTITIAL LUNG DISEASE 7 0.0001
878 NEOPLASM PROGRESSION 5 0.0001
879 CARDIO-RESPIRATORY ARREST 6 0.0001
880 INJECTION SITE PAIN 44 0.0001
881 KNEE ARTHROPLASTY 3 0.0001
882 DRY SKIN 19 0.0001
883 SUICIDAL IDEATION 13 0.0001
884 BLINDNESS UNILATERAL 2 0.0001
885 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
886 ADVERSE EVENT 13 0.0001
887 EMOTIONAL DISTRESS 17 0.0001
888 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
889 SWELLING FACE 9 0.0001
890 DEVICE DISLOCATION 6 0.0001
891 BLOOD GLUCOSE INCREASED 26 0.0001
892 PRODUCT PRESCRIBING ISSUE 3 0.0001
893 DRUG EFFECT INCOMPLETE 5 0.0001
894 INJECTION SITE ERYTHEMA 17 0.0001
895 PROSTATE CANCER 11 0.0001
896 ERYTHEMA 28 0.0001
897 APPLICATION SITE PAIN 3 0.0001
898 DEATH 117 0.0001
899 RESPIRATORY DISORDER 4 0.0001
900 IRRITABILITY 8 0.0001
901 APPLICATION SITE PRURITUS 3 0.0001
902 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
903 ILL-DEFINED DISORDER 8 0.0001
904 DRUG EFFECT DECREASED 7 0.0001
905 ARRHYTHMIA 6 0.0001
906 PRODUCT PRESCRIBING ERROR 3 0.0001
907 THERAPY INTERRUPTED 9 0.0001
908 MOOD SWINGS 4 0.0001
909 HYPOGLYCAEMIA 6 0.0001
910 LACTIC ACIDOSIS 4 0.0001
911 EXTRA DOSE ADMINISTERED 5 0.0001
912 PSORIATIC ARTHROPATHY 5 0.0001
913 LUNG DISORDER 6 0.0001
914 OSTEONECROSIS 4 0.0001
915 EXTRAPYRAMIDAL DISORDER 3 0.0001
916 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
917 INFUSION RELATED REACTION 8 0.0001
918 DRUG INEFFECTIVE 158 0.0001
919 CHILLS 14 0.0001
920 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
921 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
922 ANGER 4 0.0001
923 MALIGNANT NEOPLASM PROGRESSION 12 0.0001
924 THERAPEUTIC RESPONSE DECREASED 7 0.0001
925 DEVICE LEAKAGE 5 0.0001
926 VAGINAL HAEMORRHAGE 5 0.0001
927 DISCOMFORT 7 0.0001
928 APPLICATION SITE ERYTHEMA 3 0.0001
929 DERMATITIS ATOPIC 6 0.0001
930 SYSTEMIC LUPUS ERYTHEMATOSUS 4 0.0001
931 CARDIAC FAILURE 9 0.0001
932 PRODUCT ADHESION ISSUE 4 0.0001
933 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
934 JAUNDICE 3 0.0001
935 PAIN OF SKIN 3 0.0001
936 BLOOD BILIRUBIN INCREASED 3 0.0001
937 THROAT TIGHTNESS 3 0.0001
938 RESPIRATORY ARREST 3 0.0001
939 SKIN DISCOLOURATION 5 0.0001
940 AGRANULOCYTOSIS 2 0.0001
941 PRODUCT DOSE OMISSION 7 0.0001
942 HEPATIC FUNCTION ABNORMAL 4 0.0001
943 TARDIVE DYSKINESIA 3 0.0001
944 COMA 5 0.0001
945 GENERAL PHYSICAL HEALTH DETERIORATION 12 0.0001
946 LIVER FUNCTION TEST ABNORMAL 3 0.0001
947 NEEDLE ISSUE 3 0.0001
948 ASCITES 3 0.0001
949 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
950 HEPATIC FAILURE 3 0.0001
951 DYSKINESIA 4 0.0001
952 EPILEPSY 3 0.0001
953 DRUG ADMINISTRATION ERROR 3 0.0001
954 MYOCARDIAL INFARCTION 17 0.0001
955 INCORRECT DOSE ADMINISTERED 22 0.0001
956 BONE DENSITY DECREASED 3 0.0001
957 PRODUCT QUALITY ISSUE 13 0.0001
958 DRUG-INDUCED LIVER INJURY 3 0.0001
959 ACNE 7 0.0001
960 DRUG WITHDRAWAL SYNDROME 8 0.0001
961 ANAPHYLACTIC REACTION 5 0.0001
962 ANGIOEDEMA 4 0.0001
963 MEDICATION ERROR 5 0.0001
964 THERAPY NON-RESPONDER 4 0.0001
965 HEPATIC ENZYME INCREASED 6 0.0001
966 DEVICE MALFUNCTION 6 0.0001
967 INFLUENZA LIKE ILLNESS 7 0.0001
968 TREATMENT FAILURE 7 0.0001
969 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
970 SKIN BURNING SENSATION 6 0.0001
971 C-REACTIVE PROTEIN INCREASED 3 0.0001
972 LEUKOPENIA 4 0.0001
973 INJECTION SITE SWELLING 6 0.0001
974 ABORTION SPONTANEOUS 3 0.0001
975 INJECTION SITE REACTION 5 0.0001
976 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
977 PRODUCT STORAGE ERROR 6 0.0001
978 ACCIDENTAL EXPOSURE TO PRODUCT 7 0.0001
979 NO ADVERSE EVENT 12 0.0001
980 SUICIDE ATTEMPT 4 0.0001
981 BREAST CANCER 6 0.0001
982 EXPOSURE DURING PREGNANCY 4 0.0001
983 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
984 PSORIASIS 8 0.0001
985 BLADDER CANCER 3 0.0001
986 ABNORMAL BEHAVIOUR 2 0.0001
987 INTENTIONAL OVERDOSE 3 0.0000
988 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
989 DEVICE ISSUE 4 0.0000
990 AGITATION 3 0.0000
991 AGGRESSION 2 0.0000
992 DRUG DEPENDENCE 5 0.0000